LinkedIn (original) (raw)

LinkedIn

This link will take you to a page that’s not on LinkedIn

Because this is an external link, we’re unable to verify it for safety.

https://ir.spyre.com/2024-10-14-Spyre-Therapeutics-Announces-Expected-Acceleration-of-SPY003-IL-23p19-Clinical-Timelines-and-Presentations-at-UEGW-supporting-Spyres-Portfolio-of-Potentially-Best-in-Class-Antibodies-and-Combinations

This experience is optimized for Chrome, Edge, and Safari